Kawasaki disease with bronchopneumonia: A case report

Authors

  • Dayana Nicholas Clinical Pharmacy and Pharmacy Practice Unit, Faculty of Pharmacy, AIMST University, Kedah
  • Kenneth Nelson Clinical Pharmacy and Pharmacy Practice Unit, Faculty of Pharmacy, AIMST University, Kedah
  • Azmi Sarriff Discipline of Clinical Pharmacy, School of pharmacy, University Sains Malaysia, Penang

DOI:

https://doi.org/10.3329/icpj.v1i8.11256

Keywords:

Systemic vasculitis, children, coronary arteries, outcome, immunoglobulin G, antibodies

Abstract

disease (KD) is an acute systemic vasculitis that predominantly affects pre-school aged children. It is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, changes in the extremities, rash, and cervical lymphadenopathy, and irritation and inflammation of the mouth, lips, and throat. Serious complications of KS include coronary artery dilatations and aneurysms, and KS is a leading cause of acquired heart disease. It has a predilection to coronary arteries, and its precise etiology is still unknown. Many infectious agents, including viruses and bacteria, have been suggested as potential causes of the disease.

DOI: http://dx.doi.org/10.3329/icpj.v1i8.11256

International Current Pharmaceutical Journal 2012, 1(8): 226-228

 

Downloads

Download data is not yet available.
Abstract
139
PDF
49

Downloads

Published

2012-07-05

How to Cite

Nicholas, D., Nelson, K., & Sarriff, A. (2012). Kawasaki disease with bronchopneumonia: A case report. International Current Pharmaceutical Journal, 1(8), 226–228. https://doi.org/10.3329/icpj.v1i8.11256

Issue

Vol. 1 No. 8 (2012)

Section

Review Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).